Filing Flows › Bausch Health Companies (BHC) › Q2 2026 › vs Q1 2026
Bausch Health Companies (BHC) Q2 2026 vs Q1 2026 (quarter over quarter)
Bausch Health Companies's revenue rose $328M (+13%) from $2.5B in Q1 2026 to $2.9B in Q2 2026. The biggest changes: Product sales +$325M (+13%); Other revenues +$3.0M (+12%). Operating margin 25.9% against -37.6% (+63.6 pts).
Bausch Health Companies, Q2 2026: revenue $2.9B (+13% year over year), operating margin 25.9%, net earnings $258M, operating cash flow $670M. The chart draws each line against Q1 2026, the increases inside each band.
Margins
| Q2 2026 | Q1 2026 | Change | |
|---|---|---|---|
| Operating margin | 25.9% | -37.6% | +63.6 pts |
| Net margin | 9.0% | -56.4% | +65.4 pts |
| Free cash flow margin | 20.8% | 4.8% | +16.0 pts |
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Product sales | $2.8B | $2.5B | $325M | +13% |
| Other revenues | $27.0M | $24.0M | $3.0M | +12% |
| Revenue | $2.9B | $2.5B | $328M | +13% |
| Operating profit | $740M | −$950M | $1.7B | — |
| Costs & expenses | $2.1B | $3.5B | −$1.4B | -39% |
| Pre-tax earnings | $348M | −$1.4B | $1.7B | — |
| Other expense, net | $392M | $404M | −$12.0M | -3% |
| Research & development | $173M | $163M | $10.0M | +6% |
| SG&A | $907M | $861M | $46.0M | +5% |
| Other operating costs | $1.0B | $2.5B | −$1.4B | -58% |
| Net earnings | $258M | −$1.4B | $1.7B | — |
| Minority interests | $2.0M | −$8.0M | $10.0M | — |
| Income tax | $88.0M | $77.0M | $11.0M | +14% |
| Depreciation & amortization | $281M | $295M | −$14.0M | -5% |
| Share-based compensation | $54.0M | $52.0M | $2.0M | +4% |
| Working capital & other | $77.0M | $1.3B | −$1.2B | -94% |
| Operating cash flow | $670M | $230M | $440M | +191% |
| Free cash flow (OCF − capex) | $593M | $121M | $472M | +390% |
| Capital expenditures | $77.0M | $109M | −$32.0M | -29% |
Questions
How much did Bausch Health Companies's revenue grow quarter over quarter in Q2 2026?
Bausch Health Companies's revenue rose $328M (+13%) from $2.5B in Q1 2026 to $2.9B in Q2 2026.
What drove Bausch Health Companies's revenue change in Q2 2026?
Product sales +$325M (+13%); Other revenues +$3.0M (+12%).